The Colorado State University Animal Cancer Center (ACC) is the preeminent cancer center for animals offering the latest in diagnostics and treatment for all kinds of cancer in companion animals including surgery, chemotherapy and radiation therapy. The 35,000 square foot ACC is physically attached to the CSU Veterinary Teaching Hospital (VTH). Cancer patients that come to the ACC are evaluated, diagnosed and treated through the clinical oncology service at the VTH. The oncology service also coordinates clinical trials for both human and veterinary needs. Basic research in cancer at CSU includes areas in cancer immunology, pharmacology, molecular oncology, imaging, pathology, radiation oncology and nutritional intervention. Basic research capabilities include both in vitro and in vivo models, as well as coordination with the clinical service for design and implementation of clinical trials. More information is available at www.csuanimalcancercenter.org

Colorado State University’s Mycobacteria Research Laboratory (MRL) occupies multiple laboratory and BSL-3 laboratories and is comprised of more than 100 research personnel. All aspects of tuberculosis are studied at the MRL including: vaccines, adjuvants, diagnostics, biologics, small molecule therapeutics, research materials and tools, and epidemiological, social, and economic modeling. Considerable research is focused on both multiple and extremely resistant strains (MDR-TB and XDR-TB respectively).

The Engines & Energy Conversion Laboratory (EECL) has won numerous awards and is a recognized world leader in developing significant and commercially practicable solutions to global energy challenges. With a focus towards marketdriven solutions, products developed at the EECL in partnership with industrial sponsors have reduced pollution in the atmosphere by millions of tons and have saved over 14 billion cubic feet of natural gas. Ongoing research and product development includes clean combustion technologies, algae-based biofuels, cookstoves, and smart grid innovations for application in transportation, air quality, and distributed energy. Specialized facilities include large-bore engine lab, diesel lab, grid-based renewable energy lab, and advanced clean cookstove lab. More information at: www.eecl.colostate.edu

C2D2 is part of a State of Colorado-sponsored initiative to generate economic development based on bioscience research (HB-08-1001) that is creating a unique academic drug discovery model which will be available to researchers within Colorado. Utilizing the scientific expertise and resources which exist at Colorado research institutions, C2D2 fosters multi-disciplinary and inter-institutional drug discovery collaborations. Through the combination of collaborations, providing drug discovery expertise, and establishing key elements of drug discovery infrastructure, C2D2 will advance drug discovery programs. Currently medicinal chemistry support is available to Colorado companies as well as nationally. Also, a compound collection is being constructed for screening targets.

VetDC is a new Colorado startup company, founded to take advantage of technology development opportunities arising from Colorado State University’s world-renowned Veterinary Teaching Hospital and Animal Cancer Center. Many companies seek out veterinary models to conduct proof of concept studies on drugs, devices, and diagnostics in development for human commercialization. In many cases, the innovator companies have not considered potential veterinary applications of their technology and do not have strategic interest or resources to invest in developing their technology for animal health markets. VetDC was created to provide an opportunity to maximize their product investment by taking license to novel technologies exclusively for animal health markets and by performing the necessary studies to position such products for animal use.